MAP PHARMACEUTICALS, INC. Stock-Based Compensation
MAP PHARMACEUTICALS, INC. reported Stock-Based Compensation of $1.97 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was $1.97M, a 14.78% increase year-over-year.
- MAP PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was $2.03M, a 23.19% increase year-over-year.
- MAP PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $2.29M, a 7.86% increase year-over-year.
- MAP PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $1.86M, a 5.20% increase year-over-year.
- MAP PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2011 was $7.34M, a 11.75% increase from fiscal 2010.
- MAP PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2010 was $6.57M, a 33.71% increase from fiscal 2009.
- MAP PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2009 was $4.92M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 96 month | Share-based Payment Arrangement, Noncash Expense 99 month | Share-based Payment Arrangement, Noncash Expense 102 month | Share-based Payment Arrangement, Noncash Expense 105 month | Share-based Payment Arrangement, Noncash Expense 108 month | Share-based Payment Arrangement, Noncash Expense 111 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $1.97M 10-Q · filed 2012-11-06 | $3.99M derived: sum of 2 quarters · filed 2012-11-06 | $6.29M 10-Q · filed 2012-11-06 | $8.15M derived: sum of 4 quarters · filed 2012-11-06 | $31.47M 10-Q · filed 2012-11-06 | |||||
| 2012-06-30 | $2.03M 10-Q · filed 2012-07-27 | $4.32M 10-Q · filed 2012-07-27 | $6.18M derived: sum of 3 quarters · filed 2012-07-27 | $7.89M derived: sum of 4 quarters · filed 2012-11-06 | $29.51M 10-Q · filed 2012-07-27 | |||||
| 2012-03-31 | $2.29M 10-Q · filed 2012-05-08 | $4.15M derived: sum of 2 quarters · filed 2012-05-08 | $5.86M derived: sum of 3 quarters · filed 2012-11-06 | $7.51M derived: sum of 4 quarters · filed 2012-11-06 | $27.48M 10-Q · filed 2012-05-08 | |||||
| 2011-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $3.57M derived: sum of 2 quarters · filed 2012-11-06 | $5.22M derived: sum of 3 quarters · filed 2012-11-06 | $7.34M 10-K · filed 2012-03-30 | $25.18M 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | $1.71M 10-Q · filed 2012-11-06 | $3.36M derived: sum of 2 quarters · filed 2012-11-06 | $5.48M 10-Q · filed 2012-11-06 | $7.25M derived: sum of 4 quarters · filed 2012-11-06 | $23.32M 10-Q/A · filed 2012-03-30 | |||||
| 2011-06-30 | $1.65M 10-Q · filed 2012-07-27 | $3.77M 10-Q · filed 2012-07-27 | $5.54M derived: sum of 3 quarters · filed 2012-07-27 | $7.25M derived: sum of 4 quarters · filed 2012-07-27 | $21.61M 10-Q/A · filed 2012-03-30 | |||||
| 2011-03-31 | $2.13M 10-Q · filed 2012-05-08 | $3.89M derived: sum of 2 quarters · filed 2012-05-08 | $5.60M derived: sum of 3 quarters · filed 2012-05-08 | |||||||
| 2010-12-31 | $1.77M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $3.48M derived: sum of 2 quarters · filed 2012-03-30 | $6.57M 10-K · filed 2012-03-30 | |||||||
| 2010-09-30 | $1.71M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-30 | $4.80M 10-Q/A · filed 2012-03-30 | ||||||||
| 2010-06-30 | $3.09M 10-Q/A · filed 2012-03-30 | |||||||||
| 2009-12-31 | $4.92M 10-K · filed 2012-03-30 |